Impact of Bortezomib On the Treatment of Antibody Mediated Rejection Following Kidney Transplant.

被引：0
|
作者：
Kassis, Y. [1 ]
Shetty, A. [1 ]
Flechner, S. [1 ]
Chiesa-Vottero, A. [2 ]
Fatica, R. [1 ]
机构：
[1] Cleveland Clin Fdn, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B869
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [1] Impact of Bortezomib On the Treatment of Antibody Mediated Rejection Following Kidney Transplant.
    Kassis, Y.
    Shetty, A.
    Flechner, S.
    Chiesa-Vottero, A.
    Fatica, R.
    [J]. TRANSPLANTATION, 2014, 98 : 512 - 512
  • [2] The Addition of Bortezomib to a Rituximab Based Antibody Mediated Rejection Treatment Protocol in Lung Transplant.
    Galle, M.
    Stracener, P.
    Warrior, K.
    Lyons, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 991 - 991
  • [3] Adjunctive Bortezomib Therapy for Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients.
    McDermott, J.
    Lee, J.
    Aull, M.
    Muthukumar, T.
    Hartono, C.
    Serur, D.
    Lee, J.
    Sharma, V.
    Kim, J.
    Watkins, A.
    Kapur, S.
    Suthanthiran, M.
    Dadhania, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 328 - 328
  • [4] Bortezomib Treatment in Antibody Mediated Rejection After Kidney Transplantation
    Lee, J.
    Lee, J.
    Kim, B.
    Park, Y.
    Ju, M.
    Kim, M.
    Kim, S.
    Kim, Y.
    Huh, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [5] BORTEZOMIB TREATMENT IN ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Lee, Juhan
    Beom, Seok Kim
    Jae, Geun Lee
    Seung, Hwan Song
    Hye, Jin Kim
    Park, Yongjung
    Yu, Seun Kim
    Kyu, Ha Huh
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 207 - 208
  • [6] A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
    Eskandary, Farsad
    Regele, Heinz
    Baumann, Lukas
    Bond, Gregor
    Kozakowski, Nicolas
    Wahrmann, Markus
    Hidalgo, Luis G.
    Haslacher, Helmuth
    Kaltenecker, Christopher C.
    Aretin, Marie-Bernadette
    Oberbauer, Rainer
    Posch, Martin
    Staudenherz, Anton
    Handisurya, Ammon
    Reeve, Jeff
    Halloran, Philip F.
    Boehmig, Georg A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (02): : 591 - 605
  • [7] TREATMENT OF ACUTE ANTIBODY MEDIATED REJECTION USING BORTEZOMIB IN KIDNEY TRANSPLANTATION
    Sin, Yong Hun
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 460 - 460
  • [8] USE OF BORTEZOMIB AS RESCUE THERAPY FOR ANTIBODY MEDIATED REJECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Brennan, J.
    Brakeman, P.
    Gonzalez, L.
    [J]. PEDIATRIC TRANSPLANTATION, 2015, 19 : 86 - 86
  • [9] Tocilizumab for treatment of antibody mediated rejection in kidney transplant patients
    Szabo, Eszter
    Marton, Adrienn
    Remport, Adam
    Torok, Szilard
    Patonai, Attila
    Piros, Laszlo
    Fintha, Attila
    Szijarto, Attila
    Wagner, Laszlo
    Cseprekal, Orsolya
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2680 - I2680
  • [10] Bortezomib for antibody-mediated rejection of kidney transplant in youth: Associations with donor-specific antibody
    Fulchiero, Rosanna
    Galea, Lauren
    Hewlett, Jennifer
    Savant, Jonathan D.
    Lopez, Sonya
    Amaral, Sandra
    Viteri, Bernarda
    [J]. PEDIATRIC TRANSPLANTATION, 2024, 28 (05)
12345